Challenges of HIV Lymphoma Clinical Trials in Africa: Lessons From the AIDS Malignancy Consortium 068 Study

Robert Matthew Strother(University of Otago), Susan E. Krown(Memorial Sloan Kettering Cancer Center), Elson T. Mberi(University of Zimbabwe), Ethel Cesarman(Cornell University), Ntokozo Ndlovu(University of Zimbabwe), Jeannette Y. Lee(University of Arkansas at Little Rock), Ariela Noy(Memorial Sloan Kettering Cancer Center), Scot C. Remick(University Hospitals of Cleveland), Amy Chadburn(Cornell University), Abrahams Omoding(Uganda Cancer Institute), Satish Gopal(Center for Global Health), Meg Wirth(Emmes (United States)), Bongani Kaimila(University of Malawi), Naftali Busakhala(Moi University)
JCO Global Oncology
July 7, 2020
10.1200/go.20.00152
Cited by 6

Related Papers

Kaposi sarcoma
|Nature Reviews Disease Primers|2019|707
Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee.
|Journal of Clinical Oncology|1989|483
A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model
|Blood|2001|427
Preliminary Observations on the Effect of Recombinant Leukocyte a Interferon in Homosexual Men with Kaposi's Sarcoma
|New England Journal of Medicine|1983|358
RETRACTED: KSHV vFLIP Is Essential for the Survival of Infected Lymphoma Cells
|The Journal of Experimental Medicine|2004|326